highly significantP = 0.011
Significantly, we found that symptom score explained 74% of the variation in patient sample variation along PCA1, a strong and highly significant correlation (Spearman's rho = 0.86, P = 0.011) ( Figure 2C ).
Significantly, we found that symptom score explained 74% of the variation in patient sample variation along PCA1, a strong and highly significant correlation (Spearman's rho = 0.86, P = 0.011) ( Figure 2C ).
( D ) Enhancer probes show a strong trend towards loss of methylation in patients versus controls.